Podcasts > Huberman Lab > Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

By Scicomm Media

In this episode of the Huberman Lab, Dr. Matthew Johnson explores the science of psychedelic compounds and their effects on perception, emotion, and cognition. He explains how substances like LSD, psilocybin, and MDMA interact with the brain's serotonin system and how various factors—including dosage and environment—influence the psychedelic experience.

The discussion covers both the fundamentals of how psychedelics work in the brain and their potential therapeutic applications. Johnson shares insights from clinical trials at Johns Hopkins that investigate psychedelic therapy for conditions such as smoking cessation and end-of-life distress. He also discusses ongoing research into using psychedelics to treat brain injuries and enhance cognitive function in retired athletes who have experienced repetitive head impacts.

Listen to the original

Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

This is a preview of the Shortform summary of the Jul 24, 2025 episode of the Huberman Lab

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.

Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

1-Page Summary

Defining and Classifying Psychedelics

In a discussion between Andrew Huberman and Matthew Johnson, they explore the nature of psychedelics - substances that profoundly alter perception, emotion, and cognition. These compounds, including LSD, psilocybin, DMT, mescaline, [restricted term], and MDMA, primarily work by targeting the brain's serotonin system, specifically the serotonin 2A receptor.

Effects and Variables in Psychedelic Experiences

Johnson explains that psychedelic experiences can range from profound to extremely challenging, with substances like LSD and psilocybin more likely to induce "bad trips" compared to MDMA. In controlled settings, about one-third of participants may experience a challenging trip with high doses of psilocybin. The nature of these experiences largely depends on the specific compound, dosage, and environmental factors.

How Psychedelics Alter Perception and Self-Image

According to Johnson, psychedelics can disrupt our brain's typical top-down processing approach, leading to a dissolution of existing mental models. This disruption can result in significant re-evaluations of how we relate to the world and ourselves. The substances can temporarily reduce identity rigidity, expanding one's sense of possibility and agency. Even challenging experiences can lead to transcendental insights if the individual can surrender to the experience.

Therapeutic Applications

Johnson discusses promising clinical trials at Johns Hopkins using psychedelic therapy for various conditions, including smoking cessation and end-of-life distress. The therapy involves careful preparation, a supportive environment, and integration of insights. Participants often report lasting positive changes in their thought patterns and behaviors.

Regarding neurological conditions, preliminary research suggests potential benefits for brain injury and stroke recovery. Johnson plans to conduct studies with retired athletes who have experienced repetitive head impacts, using advanced imaging to investigate whether psychedelics can treat associated depression and enhance cognitive functions.

1-Page Summary

Additional Materials

Clarifications

  • Psychedelics primarily work by interacting with the brain's serotonin system, specifically targeting the serotonin 2A receptor. This receptor is a subtype of the serotonin receptor family and is known to play a crucial role in mediating the effects of psychedelics on perception, emotion, and cognition. By binding to the serotonin 2A receptor, psychedelics modulate neural activity in key brain regions, leading to altered states of consciousness and profound psychological effects. Understanding this mechanism helps researchers explore how psychedelics induce their unique effects and potential therapeutic applications.
  • "Bad trips" are negative and distressing experiences that can occur during psychedelic use, characterized by intense fear, anxiety, confusion, and paranoia. Factors contributing to a bad trip include high doses, pre-existing mental health conditions, and uncomfortable settings. These experiences can be psychologically challenging but are often temporary and can sometimes lead to personal insights and growth. Proper set and setting, along with guidance from trained professionals, can help mitigate the risk of a bad trip.
  • Psychedelics can temporarily reduce identity rigidity, which is the inflexible attachment to one's self-concept. This reduction allows individuals to explore different perspectives and aspects of themselves more openly. By loosening rigid self-definitions, psychedelics can facilitate profound self-reflection and personal growth. This process can lead to expanded awareness, increased empathy, and a greater sense of interconnectedness with others and the world.
  • In psychedelic therapy, integration of insights involves helping individuals make sense of their experiences and apply newfound perspectives to their daily lives. Therapists work with patients to process and understand the thoughts, emotions, and realizations that emerged during the psychedelic session. This process aims to facilitate lasting positive changes by incorporating the insights gained from the psychedelic experience into the individual's overall mental and emotional well-being. Integration sessions often focus on translating the profound or challenging aspects of the psychedelic journey into actionable steps for personal growth and healing.
  • Preliminary research suggests that psychedelics like psilocybin and LSD may have potential benefits for brain injury and stroke recovery by promoting neuroplasticity and reducing inflammation in the brain. These substances could potentially aid in cognitive and motor function recovery post-injury. Studies are exploring how psychedelics might help with conditions like depression and cognitive impairment following brain injuries or strokes. The research aims to understand the mechanisms through which psychedelics could support brain healing and recovery processes.

Counterarguments

  • The efficacy and safety of psychedelics for therapeutic use are still under investigation, and while promising, they are not yet fully understood or approved for widespread clinical use.
  • The claim that about one-third of participants may experience challenging trips with high doses of psilocybin is based on controlled settings, which may not reflect real-world use where setting and support may vary greatly.
  • The idea that psychedelics can reduce identity rigidity and expand one's sense of possibility and agency may not apply to all individuals, and some may experience increased anxiety or confusion regarding their identity.
  • While participants often report lasting positive changes, the long-term effects of psychedelic use are not fully known, and there may be risks of negative psychological impacts that are not yet fully documented.
  • The potential benefits of psychedelics for brain injury and stroke recovery are preliminary and require more extensive research to confirm their efficacy and safety.
  • The planned studies with retired athletes to investigate the treatment of depression and enhancement of cognitive functions are speculative until conducted and peer-reviewed.
  • The therapeutic applications of psychedelics often require a controlled environment and professional support, which may not be accessible or replicable outside of research settings, limiting their practical use.
  • The disruption of the brain's typical top-down processing approach may not always be beneficial and could potentially lead to disorientation or distress in some individuals.
  • The classification of MDMA as a psychedelic is sometimes debated, as it primarily exhibits empathogenic and entactogenic properties, which are distinct from the classic psychedelics like LSD and psilocybin.

Get access to the context and additional materials

So you can understand the full picture and form your own opinion.
Get access for free
Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

Defining and Classifying Psychedelics

The discussion between Andrew Huberman and Matthew Johnson explores the categorization of psychedelics, their effects on the mind, and the variables influencing experiences during their use.

Psychedelics Alter Reality and Self-Perception

Psychedelics are a class of substances with the power to profoundly alter perception, emotion, and cognition. The term includes a variety of compounds such as LSD, psilocybin, DMT, mescaline, [restricted term], and MDMA. These substances, particularly LSD and psilocybin, target the serotonin system in the brain.

"Psychedelic" Term Includes LSD, Psilocybin, [restricted term], MDMA

Discussion highlights that classic psychedelics primarily function as agonists or partial agonists at the serotonin 2A receptor. This action is what influences the altered states of mind associated with these substances, such as shifts in perception and emotional well-being, along with changes in cognition.

Effects of Psychedelics Depend On Compound, Dose, and Individual Traits

The experiences elicited by psychedelics can range from profound to extremely unsettling, with the potential for both enlightening and frightening "bad trips."

Psychedelics: Profound Experiences and Frightening "Bad Trips"

Johnson points out the unpredictability of psychedelic experiences, cautioning that participants in research trials might encounter the most beautiful or the most terrifying moments of their lives. He mentions that with MDMA, the likelihood of a challenging experience is much lower than with substances like LSD or psilocybin.

Psychedelics' Subjective Experience Is Sh ...

Here’s what you’ll find in our full summary

Registered users get access to the Full Podcast Summary and Additional Materials. It’s easy and free!
Start your free trial today

Defining and Classifying Psychedelics

Additional Materials

Clarifications

  • Agonists or partial agonists at the serotonin 2A receptor are substances that interact with a specific receptor in the brain. Agonists fully activate the receptor, while partial agonists activate it to a lesser extent. In the context of psychedelics, their action at the serotonin 2A receptor is what leads to altered states of consciousness and perception. This interaction plays a key role in the effects experienced when using psychedelics.
  • Set and setting in the context of psychedelic experiences encompass the mindset and environment in which a person consumes these substances. "Set" denotes the individual's mental state, including emotions and expectations, while "setting" represents the physical and social surroundings. These factors significantly influence the nature and outcome of psychedelic experiences, whether in therapeutic or recreational settings. The concept of set and setting has been crucial in shaping the understanding and practice of psychedelic therapy, emphasizing the importance of creating supportive and conducive environments for such experiences.
  • Psychedelics, when use ...

Counterarguments

  • The classification of substances like [restricted term] and MDMA as psychedelics is debated, as some researchers categorize them differently due to their distinct pharmacological profiles and effects.
  • The role of the serotonin 2A receptor in the effects of psychedelics is well-established, but it's not the only mechanism involved; other neurotransmitter systems and receptor types also contribute to their effects.
  • The term "bad trip" can be stigmatizing and may not accurately reflect the complex nature of challenging psychedelic experiences, which can sometimes lead to personal growth or insight.
  • The influence of "set and setting" on psychedelic experiences, while significant, may not fully account for all the variability in individual responses to these substances.
  • The assertion that guides in therapeutic settings can always create a comfortable and meaningful environment may be overly optimistic, as the unpredictability of psychedelic experiences can sometimes lead to outcomes that are difficult to ma ...

Get access to the context and additional materials

So you can understand the full picture and form your own opinion.
Get access for free
Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

Mechanisms By Which Psychedelics Alter Perception and Self-Representation

Exploring how substances like LSD and psilocybin affect our mental processes, researchers delve into the complex interaction between psychedelics and the serotonin system.

Psychedelics Dissolve Brain Models, Enhancing Awareness and Perception Flexibility

Matthew Johnson discusses how our brains serve as prediction machines using a top-down processing approach, which psychedelics can disrupt, leading to a dissolution of preexisting mental models and boosting perceptual awareness and flexibility.

Profound Re-evaluation of Self and World Relationship

Psychedelics, due to their interaction with the serotonin system, are implicated in challenging the models we have of the world and ourselves. This disruption can result in significant re-evaluations of our relationship with the world around us, altering perceptions and leading individuals to experience common elements of life, like the human hand, with intense interest and a sense of rediscovery.

Psychedelics Reduce Identity Rigidity, Boost Agency and Possibility

Johnson talks about the changes in self-representation that commonly occur after a psychedelic experience. He suggests that the largest model affected by psychedelics is the self, defined by personal traits or challenges. Psychedelics can temporarily reduce the rigidity of one's identity, allowing a person to think they are capable of doing things they'd normally consider impo ...

Here’s what you’ll find in our full summary

Registered users get access to the Full Podcast Summary and Additional Materials. It’s easy and free!
Start your free trial today

Mechanisms By Which Psychedelics Alter Perception and Self-Representation

Additional Materials

Clarifications

  • Psychedelics like LSD and psilocybin interact with the serotonin system in the brain. Serotonin is a neurotransmitter that plays a crucial role in regulating mood, emotions, and cognition. When psychedelics bind to serotonin receptors, they disrupt normal brain activity, leading to altered perception, mood changes, and shifts in consciousness. This interaction is believed to be a key factor in the profound effects psychedelics have on perception, self-representation, and consciousness.
  • Brain models as prediction machines using top-down processing involve the brain's ability to generate expectations based on prior knowledge and experiences. This process allows the brain to predict incoming sensory information, shaping our perception of the world. When disrupted by psychedelics, these predictive models can break down, leading to altered perceptions and increased flexibility in how we interpret reality.
  • The "perceptual bubble related to sense of self" refers to the cognitive boundaries that define an individual's self-awareness and identity. It represents the limits within which a person perceives and interacts with the world based on their self-concept. When expanded through experiences like psychedelics, this bubble can broaden, allowing for a more profound and flexible understanding of oneself and the surrounding reality. This expansion can lead to shifts in perception, cognition, and emotional processing, potentially altering how one relates to themselves and the external environment.
  • Transcendental insights from negative experiences with psychedelics can occur when individuals surrender control during a challenging trip, leading to profound realizations or understandings about themselves or the world. By letting go of resistance and embracing the difficult aspects of the experience, individuals may reach a state of acceptance or enlightenment that can bring about personal growth or transformation. These insights often involve a deep reassessment of one's beliefs, behaviors, or perceptions, allowing for a shift ...

Counterarguments

  • The brain's top-down processing is an evolutionary adaptation that serves to efficiently process vast amounts of sensory information; suggesting that disrupting this system is beneficial oversimplifies its role and potential negative consequences.
  • The intense interest in common elements of life induced by psychedelics may not necessarily reflect a deeper truth or reality but could be a temporary alteration of perception without lasting significance.
  • The belief in the capability to do things considered impossible under the influence of psychedelics may lead to unrealistic expectations or dangerous behaviors in the absence of the substance.
  • While psychedelics might expand one's perceptual bubble, this expansion is not always accompanied by an ability to integrate these experiences into one's life in a meaningful or healthy way.
  • Negative experiences with psychedelics, even if surrendered to, can sometimes result in lasting psychological t ...

Get access to the context and additional materials

So you can understand the full picture and form your own opinion.
Get access for free
Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

Therapeutic Applications of Psychedelics

Recent conversations with experts like Matthew Johnson and Andrew Huberman have shed light on the promising effects of psychedelic therapy for various mental health conditions and the potential neurological benefits that warrant further investigation.

Psychedelic Therapy Promising For Depression, Addiction, Ptsd, End-of-life Distress

Johnson discusses how psychedelic therapy has been applied in clinical trials at Johns Hopkins, targeting conditions such as smoking cessation and end-of-life distress among cancer patients.

Psychedelics Transform Negative Thought Patterns

In studies, participants experience a profound shift in agency and self-identity after a psychedelic experience, which enables them to escape negative self-modeling, such as the notion that they cannot quit an addiction or must resign to suffering. Participants consistently report a newfound ability to choose healthier behaviors and thought patterns. These changes are attributed to the psychedelic experience, which appears to enable a reprocessing of trauma with lasting effects, akin to memory reconsolidation.

Psychedelic Therapy: Preparation, Supportive Environment, and Insight Integration

Preparation for psychedelic therapy involves establishing a therapeutic rapport and informing participants about the variability of psychedelic experiences. Johnson emphasizes that the environment plays a significant role; creating a "container" where patients learn to relinquish control and build trust with the therapist is crucial. The therapist helps navigate the psychedelic experience, providing reassurance and safety protocols, such as administering [restricted term] under the tongue to lower blood pressure if necessary. Johnson further shows interest in high doses of psychedelics for treating depression, suggesting that such doses could have lasting benefits.

Psychedelics' Therapeutic Benefits for Neurological Conditions Need More Research

Huberman and Johnson discuss the frontiers of psychedelic research, particularly its potential in treating neurological injuries and disorders.

Reports: Psychedelics May Aid Brain Injury or Stroke Recovery

Anecdotes an ...

Here’s what you’ll find in our full summary

Registered users get access to the Full Podcast Summary and Additional Materials. It’s easy and free!
Start your free trial today

Therapeutic Applications of Psychedelics

Additional Materials

Clarifications

  • Memory reconsolidation is a process where previously formed memories become temporarily unstable when recalled, allowing for potential modification or updating before being re-stabilized. This phenomenon enables the brain to incorporate new information or perspectives into existing memories, potentially leading to changes in behavior or thought patterns. It is a crucial aspect of how memories can be updated and adapted over time based on new experiences or insights. Memory reconsolidation plays a role in therapeutic interventions like psychedelic therapy by facilitating the reprocessing of traumatic memories to promote healing and positive behavioral changes.
  • Neuroplasticity is the brain's ability to reorganize and form new neural connections, allowing it to adapt and change in response to various factors like learning, experiences, and injuries. This process enables the brain to modify its structure and function, supporting cognitive flexibility and recovery from damage. Neuroplasticity occurs throughout life, not just in childhood, highlighting the brain's ongoing capacity for growth and adaptation. It involves changes at different levels, from individual neurons forming new connections to broader reorganization of brain regions.
  • Advanced imaging techniques like MRI are used in research to study the effects of psychedelics on the brain. MRI stands for Magnetic Resonance Imaging, a non-invasive technology that produces detailed images of the brain's structure and function. Researchers use MRI to observe changes in brain activity and connectivity before and after participants undergo psychedelic experiences. This helps in understanding how psy ...

Counterarguments

  • While psychedelic therapy shows promise, it is not universally effective and may not be suitable for all individuals, particularly those with a history of psychosis or certain other mental health conditions.
  • The profound shifts reported by participants could be influenced by the expectation and setting of the study, known as the placebo effect, and may not solely be due to the pharmacological action of the psychedelics.
  • The long-term effects and safety of high doses of psychedelics are not fully understood, and there may be risks associated with such treatments that have not yet been identified.
  • The supportive environment and therapist involvement are critical components of psychedelic therapy, and the positive outcomes might not be replicable outside of controlled clinical settings.
  • Anecdotal evidence is not a reliable source for validating the therapeutic benefits of psychedelics for neurological conditions, and such claims should be approached with caution until supported by rigorous scientific research.
  • The concept of neuroplasticity is complex, and while psychedelics may promote it, ...

Get access to the context and additional materials

So you can understand the full picture and form your own opinion.
Get access for free

Create Summaries for anything on the web

Download the Shortform Chrome extension for your browser

Shortform Extension CTA